Total Funding
55
49
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
216353
A biomedical acceleration and development company .
Denis D Corin: CEO and ChairmanPast Role: TapImmune, President
Enrique Navas: Founder
About the Company
Q BioMed Inc. 'Q' is a biomedical acceleration and development company. They are focused on licensing and acquiring undervalued and under-appreciated biomedical assets. Q is dedicated to providing these target assets, the strategic resources, developmental support, and expansion capital to ensure they meet their potential. The end result
being value recognition and ultimately enabling them to provide products to patients in need.
